It looks as if Cortex is doing everything it can to get the results made available as quickly as possible. Roger expressed previously to me, that absolute control is not maintained when working with third party entities. I would think there is not much else to be done except offer to pay the overtime necessary to complete it faster. They'll just have to hope that it is utilized.
"Bob, We know that the DSMB(Data Safety Monitoring Board) and the CRO are very busy crunching the data. It is clear that the CRO needed more assistance from the consultants on the DSMB in its analysis so they have asked for help. We also have paid the CRO an extra incentive fee to get their personnel to work overtime to get the job done more quickly. So from the standpoint of Cortex, we need to now wait until we can see results which are sufficiently complete to provide an unambiguous response to the public. The first study to be completed and analyzed will be the Parexel dose ranging study. Roger"
Market Data 
Markets 
AI
